Comments
Osiris rises on nod for wound treatment reimbursement
31.05.2012. | (Reuters) - Shares of Osiris Therapeutics Inc rose 15 percent on Wednesday, after U.S. health regulators said the stem-cell technology company's wound treatment was eligible for reimbursement when used in hospitals in out-patient settings or in ambulances....
